(Q77344419)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11740992%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

title

Radiation therapy of stage I and II non-small cell lung cancer (NSCLC) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11740992%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

D Zierhut

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11740992%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

C Bettscheider

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11740992%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

K Schubert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11740992%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M van Kampen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11740992%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M Wannenmacher

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11740992%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11740992%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11740992%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

34 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11740992%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

S39-43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11740992%20AND%20SRC:MED&resulttype=core&format=json

New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

A new international staging system for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Progress in lung cancer: non-oat cell (non-small cell lung cancer).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Incidence of local recurrence and second primary tumors in resected stage I lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Results of surgical treatment of patients with T3 non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Radical radiotherapy for early nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Curative radiotherapy of early operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Surgical treatment of non-small cell lung cancer by stage

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. The Ludwig Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Mediastinal metastases in bronchogenic carcinoma: influence of postoperative irradiation, cell type, and location

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small-cell lung cancer: results of Eastern Cooperative Oncology Group 4593

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

[Possibilities of an open magnetic resonance scanner integration in therapy simulation and three-dimensional radiotherapy planning]

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

[MRI simulation of bronchogenic carcinomas using an open low-field MRI]

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900381-6

7 January 2021

10.1016/S0169-5002(01)00381-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11740992%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference